Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae Iwasawa

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
The Oncologist|June 27, 2022
Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS StudySatoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu, et al.
Respiratory Research|November 11, 2021
Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumoniasTomoyuki Fujisawa, Yasuoki Horiike, Ryoko Egashira, et al.
Cancer Science|October 30, 2020
Treatment and relapse of interstitial lung disease in nivolumab-treated patients with non-small cell lung cancerMasafumi Sata, Shinichi Sasaki, Katsunori Oikado, et al.
Scientific Reports|June 6, 2022
Prognostic implication of IgG4 and IgG1-positive cell infiltration in the lung in patients with idiopathic interstitial pneumoniaMasamichi Komatsu, Hiroshi Yamamoto, Takeshi Uehara, et al.
ERJ Open Research|September 3, 2021
Clinical characteristics of immunoglobulin G<sub>4</sub>-positive interstitial pneumoniaMasamichi Komatsu, Hiroshi Yamamoto, Shoko Matsui, et al.
Histopathology|October 21, 2016
The pathological features of idiopathic interstitial pneumonia-associated pulmonary adenocarcinomasYoko Kojima, Koji Okudela, Mai Matsumura, et al.
Cancer Science|October 24, 2020
Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non-small cell lung cancerYoshinobu Saito, Shinichi Sasaki, Katsunori Oikado, et al.
ERJ Open Research|September 15, 2022
Respiratory lesions in IgG4-related disease: classification using 2019 American College of Rheumatology/European League Against Rheumatism criteriaMasamichi Komatsu, Hiroshi Yamamoto, Shoko Matsui, et al.
Future Oncology (London, England)|April 26, 2019
Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanomaTomohisa Baba, Fumikazu Sakai, Terufumi Kato, et al.
Respiratory Investigation|September 7, 2020
Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 casesKota Murohashi, Eri Hagiwara, Takaaki Kitayama, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
The Oncologist|June 27, 2022
Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS StudySatoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu, et al.
Respiratory Research|November 11, 2021
Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumoniasTomoyuki Fujisawa, Yasuoki Horiike, Ryoko Egashira, et al.
Cancer Science|October 30, 2020
Treatment and relapse of interstitial lung disease in nivolumab-treated patients with non-small cell lung cancerMasafumi Sata, Shinichi Sasaki, Katsunori Oikado, et al.
Scientific Reports|June 6, 2022
Prognostic implication of IgG4 and IgG1-positive cell infiltration in the lung in patients with idiopathic interstitial pneumoniaMasamichi Komatsu, Hiroshi Yamamoto, Takeshi Uehara, et al.
ERJ Open Research|September 3, 2021
Clinical characteristics of immunoglobulin G<sub>4</sub>-positive interstitial pneumoniaMasamichi Komatsu, Hiroshi Yamamoto, Shoko Matsui, et al.
Histopathology|October 21, 2016
The pathological features of idiopathic interstitial pneumonia-associated pulmonary adenocarcinomasYoko Kojima, Koji Okudela, Mai Matsumura, et al.
Cancer Science|October 24, 2020
Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non-small cell lung cancerYoshinobu Saito, Shinichi Sasaki, Katsunori Oikado, et al.
ERJ Open Research|September 15, 2022
Respiratory lesions in IgG4-related disease: classification using 2019 American College of Rheumatology/European League Against Rheumatism criteriaMasamichi Komatsu, Hiroshi Yamamoto, Shoko Matsui, et al.
Future Oncology (London, England)|April 26, 2019
Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanomaTomohisa Baba, Fumikazu Sakai, Terufumi Kato, et al.
Respiratory Investigation|September 7, 2020
Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 casesKota Murohashi, Eri Hagiwara, Takaaki Kitayama, et al.
Pageof 17